A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)
Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
Used to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.